Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Neuropharmacology. 2009 Sep 6;58(2):515–527. doi: 10.1016/j.neuropharm.2009.08.019

Table 2.

Distance measurements between the D1 and D2 lobes of GluK1–LBC.

Ligand Distance average (Å) from MD Distance (Å) from
X-ray


Chain ID Ae Be Ce De Ae Be Ce De
ATPOa A 11 10.5 12.5 12.5
(S)-glutamateb A 8.4 9 3 6.7 7.3 8.5 3 6.6
B 8.5 9 3.1 6.6 7.2 8.7 2.9 6.6
Domoatec A 9.5 9.3 3.9 6.8 6.9 9 6.7 9.2
B 9.6 9.8 3.6 7.5 6.9 9 6.7 9.2
MSVIII-19d A 9.1 9.1 3 6.7 7.6 8.9 3.3 6.6
B 8.4 9 3 6.7 7.5 8.7 2.9 6.6
apo A 7.7 9.6 3.3 7.1
B 7.5 8.5 3.2 7
neoDH A 8.6 8.8 3.6 6.9
B 8.2 8.9 3.2 6.7
8-deoxy-neoDH A 8 9.1 3 6.6
B 8 8.8 3.4 6.7
8-epi-neoDH A 9.7 8.9 3 6.7
B 8.5 9.1 3.1 7
9-F-8-epi-neoDH A 9.3 8.9 3 6.6
B 8.2 8.9 3.1 6.7
9-deoxy-neoDH #1 A 8.5 8.7 4.2 7
B 8.5 9.3 4.7 7
9-deoxy-neoDH #2 A 8.6 8.9 3 6.6
B 8.3 8.9 4.1 6.9
9-epi-neoDH A 8.3 8.8 3.2 6.7
B 9.5 9.1 3 6.7
8,9-epi-neoDH A 9.3 9 3.1 6.9
B 8.7 9.2 3.4 7
4-epi-neoDH A 9 8.8 3.1 6.8
B 8 8.8 3.1 6.8
2,4-epi-neoDH A 9.6 8.7 5.9 7.5
B 8.8 8.8 6.7 8.7
DNQX A 8.8 9.5 5.3 7.2
B 11.8 11.2 9.2 11.2
LY466195 A 12 10.5 7.4 8.7
B 10 9.2 5.5 6.6
e

A: Ser721-Glu441, B: Glu738-Pro516O, C: Asp687N-Gly490O, D: Ser689-Thr518.